Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Spare Receptors and Drug Design Maximizing Therapeutic Benefit
Editorial: J Cell Mol Pharmacol 2023, 7:175
Mitosis Under Siege the Latest Advances in Mitotic Inhibitor Drug Development
Case Report: J Cell Mol Pharmacol 2023, 7:176
Molecular Ballet Enzyme Induction and Inhibition in Therapeutics
Hypothesis: J Cell Mol Pharmacol 2023, 7:177
Dermal Absorption in Context Applications in Risk Assessment
Hypothesis: J Cell Mol Pharmacol 2023, 7:178
Evasive Maneuvers a Closer Look at How Cancer Dodges the Immune System
Commentary: J Cell Mol Pharmacol 2023, 7:179
Exploring the World of Pharmacology Unveiling the Science of Drug Action
Mini Review: J Cell Mol Pharmacol 2023, 7:180
Molecular Docking and Drug Repurposing Finding New Uses for Old Drugs
Short Communication: J Cell Mol Pharmacol 2023, 7:182
Resistance Training and Hypertrophy Training Protocols and Gains
Opinion: J Cell Mol Pharmacol 2023, 7:183
Genetic Polymorphism and Personalized Medicine Tailoring Treatment to Individuals
Case Report: J Cell Mol Pharmacol 2023, 7:184
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals